PRESCRIBING · PART D · 2024
Total Rx claims
2,040
Beneficiaries
—
Total drug cost
$776K
Distinct drugs
33
Brand share
48.3%
Top prescribed drugs
Rimegepant Sulfate219 claims
Galcanezumab-Gnlm211 claims
Tizanidine Hcl174 claims
Erenumab-Aooe145 claims
Topiramate136 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE